Victoria A. Johnson

14.0k total citations · 2 hit papers
128 papers, 10.3k citations indexed

About

Victoria A. Johnson is a scholar working on Infectious Diseases, Virology and Sociology and Political Science. According to data from OpenAlex, Victoria A. Johnson has authored 128 papers receiving a total of 10.3k indexed citations (citations by other indexed papers that have themselves been cited), including 71 papers in Infectious Diseases, 70 papers in Virology and 16 papers in Sociology and Political Science. Recurrent topics in Victoria A. Johnson's work include HIV Research and Treatment (70 papers), HIV/AIDS drug development and treatment (68 papers) and HIV/AIDS Research and Interventions (53 papers). Victoria A. Johnson is often cited by papers focused on HIV Research and Treatment (70 papers), HIV/AIDS drug development and treatment (68 papers) and HIV/AIDS Research and Interventions (53 papers). Victoria A. Johnson collaborates with scholars based in United States, United Kingdom and Spain. Victoria A. Johnson's co-authors include Douglas D. Richman, Daniel R. Kuritzkes, Bonaventura Clotet, Xiping Wei, George M. Shaw, Sebastian Bonhoeffer, Martin A. Nowak, Sajal K. Ghosh, Beatrice H. Hahn and Maria E. Taylor and has published in prestigious journals such as Nature, New England Journal of Medicine and JAMA.

In The Last Decade

Victoria A. Johnson

126 papers receiving 9.9k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Viral dynamics in human immunodeficiency virus type 1 infection

1995 2.6k citations Victoria A. Johnson et al. profile →
2015 update of the drug resistance mutations in HIV-1

2015 288 citations Vincent Cálvez, Victoria A. Johnson et al. PubMed profile →

Peers

Countries citing papers authored by Victoria A. Johnson

Since Specialization

Citations

This map shows the geographic impact of Victoria A. Johnson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Victoria A. Johnson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Victoria A. Johnson more than expected).

Fields of papers citing papers by Victoria A. Johnson

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Victoria A. Johnson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Victoria A. Johnson. The network helps show where Victoria A. Johnson may publish in the future.

Co-authorship network of co-authors of Victoria A. Johnson

This figure shows the co-authorship network connecting the top 25 collaborators of Victoria A. Johnson. A scholar is included among the top collaborators of Victoria A. Johnson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Victoria A. Johnson. Victoria A. Johnson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Dynamic source credibility and its impacts on knowledge revision 2024 ·Memory & Cognition ·Victoria A. Johnson, Reese Butterfuss, Panayiota Kendeou	1
2	The nature of misinformation in education 2023 ·Current Opinion in Psychology ·Panayiota Kendeou, Victoria A. Johnson	9
3	2015 Update of the Drug Resistance Mutations in HIV-1. 2016 ·PubMed ·Annemarie M. J. Wensing, Vincent Cálvez, Huldrych F. Günthard, Victoria A. Johnson, Roger Paredes, Deenan Pillay, Robert W. Shafer, Douglas D. Richman	56
4	2017 Update of the Drug Resistance Mutations in HIV-1. 2016 ·PubMed ·Annemarie M. J. Wensing, Vincent Cálvez, Huldrych F. Günthard, Victoria A. Johnson, Roger Paredes, Deenan Pillay, Robert W. Shafer, Douglas D. Richman	149
5	Evaluating Children’s Learning of Adaptive Response Capacities from ShakeOut, an Earthquake and Tsunami Drill in Two Washington State School Districts 2014 ·Journal of Homeland Security and Emergency Management ·Victoria A. Johnson, David Johnston, Kevin R. Ronan, Robin Peace	32
6	Children and young people's participation training workshop guide 2013 ·Goldsmiths (University of London) ·Victoria A. Johnson, (unknown), (unknown), (unknown)	2
7	Combination Antiretroviral Treatment for Women Previously Treated Only in Pregnancy 2013 ·JAIDS Journal of Acquired Immune Deficiency Syndromes ·Mary Vogler, Laura Smeaton, Rodney Wright, Sandra Wagner Cardoso, Jorge Sánchez, Rosa Infante, Laura Moran, Catherine Godfrey, Lisa M. Demeter, Victoria A. Johnson	4
8	Update of the Drug Resistance Mutations in HIV-1: December 2010 2010 ·PubMed ·Victoria A. Johnson, Françoise Brun‐Vézinet, Bonaventura Clotet, Huldrych F. Günthard, Daniel R. Kuritzkes, Deenan Pillay, Douglas D. Richman, (unknown)	71
9	Macrocyclic Inhibitors of Hsp90 2010 ·Current Topics in Medicinal Chemistry ·Victoria A. Johnson, (unknown), Lidia Nazarova, (unknown), Shelli R. McAlpine	43
10	A comprehensive study of Sansalvamide A derivatives: The structure–activity relationships of 78 derivatives in two pancreatic cancer cell lines 2009 ·Bioorganic & Medicinal Chemistry ·Po‐Shen Pan, (unknown), (unknown), Victoria A. Johnson, (unknown), (unknown), Chung‐Mao Pan, (unknown), Veronica C. Ardi, Shelli R. McAlpine	37
11	Replication Capacity in Relation to Immunologic and Virologic Outcomes in HIV-1-Infected Treatment-Naive Subjects 2009 ·JAIDS Journal of Acquired Immune Deficiency Syndromes ·Gail Skowron, John Spritzler, Jodi Weidler, Gregory K. Robbins, Victoria A. Johnson, Ellen S. Chan, David M. Asmuth, Rajesh T. Gandhi, Yolanda Lie, Michael Bates, Richard B. Pollard	4
12	Multilocus genetic interactions and response to efavirenz-containing regimens: an Adult AIDS Clinical Trials Group study 2006 ·Pharmacogenetics and Genomics ·Alison A. Motsinger‐Reif, Marylyn D. Ritchie, Robert W. Shafer, Gregory K. Robbins, Gene D. Morse, Line Labbé, G. Wilkinson, David B. Clifford, Richard T. D’Aquila, Victoria A. Johnson, Richard B. Pollard, Thomas C. Merigan, Martin Hirsch, John P. Donahue, Richard B. Kim, David W. Haas	50
13	Comparative Analysis of HIV Type 1 Genotypic Resistance across Antiretroviral Trial Treatment Regimens 2000 ·AIDS Research and Human Retroviruses ·Peter B. Gilbert, George J. Hanna, Victor De Gruttola, Javier Martínez‐Picado, Daniel R. Kuritzkes, Victoria A. Johnson, Douglas D. Richman, Richard T. D’Aquila	8
14	Multiple sites in HIV-1 reverse transcriptase associated with virological response to combination therapy 2000 ·AIDS ·(unknown), Huldrych F. Günthard, Joseph K. Wong, Richard T. D'Aquila, Victoria A. Johnson, Daniel R. Kuritzkes, Douglas D. Richman, Andrew Brown	153
15	Higher Selection Pressure from Antiretroviral Drugs in Vivo Results in Increased Evolutionary Distance in HIV-1 pol, 1999 ·Virology ·Huldrych F. Günthard, Andrew Brown, Richard T. D’Aquila, Victoria A. Johnson, Daniel R. Kuritzkes, Douglas D. Richman, Joseph K. Wong	1
16	Use of Changes in Plasma Levels of Human Immunodeficiency Virus Type 1 RNA to Assess the Clinical Benefit of Antiretroviral Therapy 1998 ·The Journal of Infectious Diseases ·Ian C. Marschner, Ann C. Collier, Robert W. Coombs, Richard T. D’Aquila, Victor DeGruttola, Margaret A. Fischl, Scott M. Hammer, Michael D. Hughes, Victoria A. Johnson, David Katzenstein, Douglas D. Richman, Laura Smeaton, Stephen A. Spector, Michael S. Saag	182
17	Impact of Care Setting on Cost and Quality Under Medicaid 1997 ·Journal of Health Care for the Poor and Underserved ·Janet Bronstein, Victoria A. Johnson, Crayton A. Fargason	4
18	Nevirapine, Zidovudine, and Didanosine Compared with Zidovudine and Didanosine in Patients with HIV-1 Infection 1996 ·Annals of Internal Medicine ·Richard T. D’Aquila, Michael D. Hughes, Victoria A. Johnson, Margaret A. Fischl, Jean‐Pierre Sommadossi, (unknown), Joseph Timpone, Maureen Myers, Nesli Basgoz, Manette T. Niu, Martin Hirsch	55
19	Combination Therapy: More Effective Control of HIV Type 1? 1994 ·AIDS Research and Human Retroviruses ·Victoria A. Johnson	16
20	Requirements for Entry into Medical Schools: The Selection of Students 1953 ·BMJ ·Victoria A. Johnson	2

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact